Keith R. Walley

Corporate Officer/Principal at University of British Columbia

Consumer Services

Health Technology

Commercial Services

Profile

Keith R.
Walley was the founder of Cyon Therapeutics, Inc. (founded in 2014) and Sirius Genomics, Inc. (founded in 2001), where he held the title of Director.
He is currently a Professor at the University of British Columbia.
Dr. Walley received a doctorate degree from the University of Manitoba.

Keith R. Walley active positions

Companies	Position	Start
University of British Columbia	Corporate Officer/Principal	-

All active positions of Keith R. Walley

Former positions of Keith R. Walley

Companies	Position	End
Cyon Therapeutics, Inc. Cyon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyon Therapuetics, Inc. operates as a clinical phase biotechnology company. It provides anti-PCSK9 which develops the treatment for sepsis-severe. The company was founded by James Russell, Keith Walley and John Boyd in May 2014 and is headquartered in Vancouver, Canada.	Founder	2014-05-01
Sirius Genomics, Inc. Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada.	Founder	-

See the detail of Keith R. Walley's experience

Training of Keith R. Walley

University of Manitoba

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith R. Walley's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Sirius Genomics, Inc. Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada.	Health Technology
Cyon Therapeutics, Inc. Cyon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyon Therapuetics, Inc. operates as a clinical phase biotechnology company. It provides anti-PCSK9 which develops the treatment for sepsis-severe. The company was founded by James Russell, Keith Walley and John Boyd in May 2014 and is headquartered in Vancouver, Canada.	Commercial Services